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Abstract 
Introduction: Medication therapy management (MTM) services are an essential way for pharmacists to provide cognitive services to 
patients and receive reimbursement.  Traditional MTM delivery has been identified as suboptimal, often done by telephone without 
any provider-patient relationship.  New ways for delivering MTM need to be explored to optimize the pharmacist’s role in this area and 
help establish the pharmacist as an essential part of the interprofessional team. 
Methods: A local public health department partnership with regional medical offices integrated pharmacist MTM services on site as 
part of patients’ routine medical care.  Referral criteria were established to identify patients who would be good candidates for services.  
Efforts were made to provide the initial consultation in the medical office, with follow-up consults being based upon patient 
preferences. 
Results: Over a 3-year period, 180 patients received 361 pharmacy MTM consultations, averaging 40 minutes in length.  A 
comprehensive medication review was performed on 87% of patients receiving these consults.  The pharmacy team identified 719 
medication-related problems, and improved participating patients’ adherence rates.  Pharmacy recommendations were accepted as is 
or modified by providers 55% of the time. Patients reported high satisfaction with the pharmacy services. 
Conclusions: A novel pharmacist MTM program integrated into provider offices demonstrated a positive impact on the clinics and on 
patients served, and successfully overcame barriers to successful MTM completion. 
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INTRODUCTION 
Interprofessional collaborative practice has widely been 
adopted as a care model that improves patient outcomes and 
improves efficiencies within the United States health care 
system.1 There are numerous examples in the literature of 
interprofessional collaborations positively impacting patient 
outcomes, communication in the medical office, and overall 
patient care.1-3 These positive results have prompted health 
science colleges and universities to establish and integrate 
interprofessional education (IPE) into various health 
professions’ curricula. In the case of pharmacy, intentional IPE 
is now an accreditation requirement for all US schools of 
pharmacy.4 This has led to tremendous growth in pharmacists 
and student pharmacists participating in various IPE practice 
models, with many best practices highlighted and specific 
outcomes, core competencies and IPE goals identified for 
prospective student pharmacists participating in this 
education.5-7 
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There is now strong evidence documenting the important role 
of the pharmacist within the interprofessional team.8-10 One 
challenge faced by pharmacist practitioners outside of large 
medical centers, however, is the ability to participate in 
interprofessional care with a physical practice site that may be 
located several miles away from the medical center and the rest 
of the interprofessional team. Much of the work done by 
community pharmacists falls under the umbrella of medication 
therapy management (MTM). Software systems utilize specific 
criteria to help identify candidates who would benefit from 
pharmacy services, and the pharmacist provides medication-
related counseling and education focused on improving the 
patient’s therapy, reducing costs, preventing adverse drug 
reactions, and improving adherence. MTM services have 
opened up opportunities for pharmacists to provide billable 
cognitive services to patients and contribute to improving 
patients’ health. Many of these interventions occur in isolation, 
however, without the rest of the medical team knowing what 
has been done and how the care fits into the patient’s overall 
care plan. Several prescription drug plans offer MTM services 
centrally by telephone consult, where there is no established 
relationship between the patient and the pharmacist providing 
the consultation.11 Patients are sometimes confused about the 
pharmacist’s role in providing cognitive MTM services, and may 
view these interventions as being redundant to the care they 
receive at the medical office. Current pilot programs are 
exploring an enhanced MTM model with purposeful intentions 
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to better engage community pharmacists that have pre-
established relationships with their patients and improve rates 
of face to face interactions.11 Efforts need to be made to better 
integrate the MTM services provided by pharmacists into the 
patient’s overall care plan, to avoid duplications or 
redundancies and to increase awareness of the pharmacy 
services the patient is receiving. There are examples of 
pharmacists working directly with providers and utilizing 
medical records to help guide their interventions and 
communicate services back to the medical team.12-14 Most of 
these, however, occur in large health system settings, not 
outpatient medical clinics. Integrating the pharmacy team into 
the clinic as part of the patient’s medical visit offers several 
advantages over other modes of delivery. This manuscript 
reports outcomes on a public health partnership where 
pharmacy MTM services were directly integrated into 
participating medical clinic settings.  
 
METHODS 
This project was designated “exempt” by the Colorado 
Institutional Review Board. The Colorado Tri-County Health 
Department (TCHD) received funding support to establish a 
multidisciplinary community health team with a prioritized 
focus on diabetes, hypertension, and medication therapy 
management. This team worked to develop partnerships with 
outpatient medical clinics in the 3-county area, offering 
specialty services in the prioritized disease states to patients 
being seen at each clinic. Participating medical offices would 
integrate members of the TCHD team on site to provide chronic 
disease services as part of the patient’s routine office visit. The 
pharmacy team was responsible for the MTM component of the 
services, and consisted of a pharmacist funded 10-15 hours per 
week along with dedicated 4th year student pharmacists on 
rotation. A manuscript focused on the educational model and 
student pharmacists’ roles and responsibilities within this 
project has been previously published.15 Referral criteria were 
established to prioritize pharmacy MTM services to the patients 
with the greatest need in each clinic due to limited pharmacist 
availability. Providers were also allowed to directly refer 
specific patients for an MTM consult, however, or the patients 
could “opt-in” if they needed pharmacy assistance. Priority was 
given to patients with the pre-specified disease states in 
diabetes or cardiovascular disease. A one-page handout was 
also developed for the dieticians and nurses on the TCHD team, 
so that they better understood the goals and benefits of MTM 
consultation and could promote these to the patients. The 
pharmacy team provided an initial consultation closely 
modeled after the comprehensive medication review (CMR) as 
defined by Medicare, with an emphasis on improving patient 
adherence and identifying and resolving any medication-
related problems (MRPs). Identified MRPs were classified by 
the pharmacist on the potential significance of the issue, based 
upon potential outcomes that could occur as a result if no 
changes were made.  MRPs that were relatively common and 
only required closer monitoring were designated as “somewhat 
significant”, and those with a likelihood of causing an unwanted 
side effect or potential secondary problem and addressing the 
problem would likely be beneficial to the patient were coined 
“significant”. Finally, those MRPs that posed serious risks to the 
patient and needed to be addressed expediently were 
considered “very significant”. The initial consultation primarily 
took place in the medical clinic, usually as part of the patient’s 
routine examination, to optimize face-to-face delivery of 
education and not require additional trips for the patient. 
Adherence was assessed utilizing the Voils standardized 
adherence scale, and patients with identified adherence 
problems were provided with various strategies to improve 
their adherence, such as pill boxes, alarms, phone applications, 
or therapy changes.16 Any recommendations to the other 
providers in the office following the initial consultation were 
made utilizing a Pharmacist/Provider Communication form 
through secure fax or email, or in the case of very significant 
problems, face to face discussions were held if the medical 
provider was accessible to expedite necessary changes. 
Examples of recommendations made by the pharmacy team 
included serious adherence issues, drug changes or 
discontinuations to resolve the MRPs, or referrals for services 
needed from a different member of the team. The prescriber 
would respond to the Communication form indicating 
implementation as is or with modifications or outright rejection 
of the recommendation. The provider would also document if 
the patient required further follow-up with them in regards to 
the identified problem. Patients who required follow-up from 
their initial consultation could choose whether to meet the 
pharmacy team again in person or receive communications by 
telephone or email. These follow-up consults were typically 
much shorter in duration and focused on any changes made to 
the patient’s therapy. All non-urgent findings and summary of 
the initial visit would be sent to the provider in a 30, 60 or 90 
day patient care plan based on provider preference. These care 
plans would be updated and sent on a scheduled basis until the 
patient was discharged from the program. 
Patient lab values were retrieved from the medical record and 
requested if they were missing.  Table 1 lists blood pressure and 
hemoglobin A1c measurements before the pharmacy MTM 
interventions and after the interventions for participating 
patients.  Statistical analysis was performed on these using the 
Wilcoxon signed-rank test (SAS Analytics Software, Cary, NC). 
 
RESULTS 
In total, 367 patients met criteria for a MTM referral across the 
3-year funding period. Of these, 180 patients (49%) successfully 
enrolled into the MTM services. Patients who did not enroll 
included those who declined services because they did not 
perceive a need to meet with the pharmacy team, along with 
those with logistic problems such as transportation challenges, 
rescheduled appointments that were not attended, or those 
patients who could not be reached. Messaging became more 
consistent across the TCHD team as the program continued, 
resulting in improved enrollment in the final year.  Within the 
population of 180 participating patients, there were 361 
medication therapy management consults provided. The 
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pharmacy team successfully provided the initial consultation at 
the patient’s medical clinic for 134 patients (74% of those 
enrolled). Approximately one-third (31%) of these patients 
were enrolled in Medicare and 11% were enrolled in Colorado 
Medicaid. Patients on average received 2 MTM consultations, 
with a range from 1 to 8 consultations across the population.  
Table 1 highlights those patients with chronic disease states of 
diabetes and/or hypertension that received MTM services. 
There were 107 patients with a diagnosis of hypertension who 
participated in pharmacy services, representing 23% of all 
hypertensive patients in the full TCHD program. Similarly, 127 
patients receiving services were diagnosed with diabetes, 
representing approximately 20% of all diabetes patients seen 
through the TCHD program. Participating patients’ systolic 
blood pressure statistically improved from baseline measures 
before the pharmacy intervention.  Diastolic blood pressure 
and A1C changes trended down but were not statistically 
significant.  Individual specific weight data were not available 
for analysis. 
 
Across all MTM consults, a total of 719 medication-related 
problems (MRPs) were identified by the pharmacy team. There 
were 326 changes to patients’ medication regimens 
recommended (45%) as a result of these problems, with 221 
(68%) requiring provider authorization for change.  Across 
these MRPs, 309 (43%) were designated “somewhat 
significant”, 217 (30%) were designated “significant”, and 44 
(6%) were designated “very significant”, based upon potential 
bad outcomes for the patient if no change was made. 
Additionally, prescription drug cost savings were identified by 
the pharmacy team and implemented in 112 cases across the 
three-year program. These costs were either direct to the 
patient or a higher cost to health plans, with the majority being 
elimination of unnecessary drugs, opting for a lower tiered 
copay option or the utilization of prescription drug discount 
programs. 
 
Figure 1 outlines providers’ responses to pharmacy 
recommendations that occurred during the medication therapy 
management consultations. A follow-up with the provider was 
recommended for 56 patients, or 25% of all of the consultations 
completed. In those patients where a follow-up was not 
required, the provider accepted pharmacy recommendations 
as is or with modifications 76% of the time. Included in the 
rejection group of data were any recommendations made 
where there was no data indicating whether the 
recommendation was approved. Reasons why a 
recommendation was not accepted included reluctance by the 
patient to start a new medication regimen, insurance formulary 
requirements, or laboratory measurements needed before a 
change could occur.  Also, in some cases providers did not 
return communication forms, patients were lost to follow up or 
patients had yet to schedule an appointment to implement 
changes at the conclusion of the program.  
 
The pharmacy team spent 203 hours of direct patient care to 
provide these patient consultations. The initial consultation 
lasted between 60-90 minutes on average, while follow-up 
consults averaged about 15 minutes in length. Additional time 
requirements on the pharmacy team, which included 
scheduling, travel to participating offices, documentation and 
follow-up from each encounter averaged around 120 minutes. 
Health-related quality of life questionnaires were given to 
participants within the TCHD cohort, including those who 
participated in the MTM consultations. Those patients who 
responded at both baseline and after receiving services are 
outlined in Table 2. Of note, this was a voluntary survey that 
was not sent to the patient until they completed all elements of 
the TCHD program.  In some cases, this was months after they 
may have received MTM services, which could explain the 
lower response rate. The PHQ4 scale, a validated 4-item patient 
health questionnaire tool used to evaluate anxiety and 
depression, was also disseminated to participants. Data from 
patients who responded at baseline and after receiving services 
are also presented in Table 2. A global assessment question was 
asked to all participants who received pharmacy services, 
stating “The pharmacy team provided support that was helpful 
to me.” 99% of the responders (87/88) rated the statement 
agree or strongly agree. Qualitative feedback regarding 
pharmacy services was very positive. A few example statements 
included “(the pharmacy team) is so caring and informative, 
teaching at its best!” and “I learned a ton and have materials to 
look back on if I have questions.” 
 
DISCUSSION 
This manuscript summarizes elements of integrated pharmacy 
services into medical offices as part of a larger collaboration 
between a local health department and several medical clinics. 
Establishing a model where a pharmacist could provide MTM 
services onsite in an outpatient facility as part of the overall 
medical consultation offers several advantages. The pharmacy 
team was able to access the patient’s medical chart and review 
their medical care as part of the assessment of the patient. 
Medication-related problems that were designated as very 
significant could be followed up upon before the patient left the 
clinic. Patients in most cases were able to receive the initial 
MTM consult as part of their overall visit, avoiding the need to 
schedule additional appointments or arrange transportation to 
another location. The established Pharmacist/Provider 
Communication form helped inform the rest of the medical 
team what was covered during the MTM encounter and any 
MRPs or adherence issues that were identified. These 
advantages have allowed pharmacists within large hospitals 
and health systems to have a positive impact on patient 
outcomes, but is relatively rare in outpatient medical clinics.12-
14 There were a number of benefits identified through this 
integration of pharmacy services. Patients rated the care they 
received from the pharmacy team very highly, both in 
quantitative tools and in qualitative statements. They also 
understood the pharmacist’s role as part of the care team 
better than traditional models where patients receive services 
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at the pharmacy, or when contracted pharmacists from a 
prescription drug plan contact their member by telephone. 
Patients who were referred for MTM services from their 
provider may have viewed the importance of receiving these 
services more importantly, since it was directly recommended 
as part of their medical care. 
 
Due to limitations in the pharmacy team’s time, criteria had to 
be established to prioritize what patients would receive MTM 
services, with an emphasis on those patients diagnosed with 
diabetes or cardiovascular disease. Based upon Table 2, 69% of 
the patients receiving interventions rated their overall health as 
“good” or less. This is consistent with national data, which 
suggest that pharmacists’ interventions are most valuable in a 
complex patient population, where patients often report their 
disease impacting them strongly and affecting their ability to 
perform activities they enjoy.17,18 If this program was sustained 
beyond the funding period, additional work to determine what 
populations would most benefit from the on-site MTM 
counseling (such as elderly populations or those patients on five 
or more medications) would be a necessary step, particularly if 
the pharmacist time available was limited. Implementing the 
use of additional data collection tools and laboratory 
measurements routinely collected before and after the 
pharmacy interventions could also better illustrate the impact 
of the pharmacy services, and could lead to greater physician 
uptake of the services. Looking at the changes in laboratory 
values for the participating patients in table 1, only systolic 
blood pressure changes were statistically significant. 
Considering the overall provider acceptance of 
recommendations, (Figure 1) a 30% initial acceptance and an 
overall 55% acceptance rate is consistent with other pharmacy 
programs.19 These numbers also included patients who were 
lost to follow up, or those who were still waiting for a follow up 
appointment with their provider, where these 
recommendations may have been addressed.  Nevertheless, it 
does suggest that there is substantial room for improvement, 
and further research could examine the nature of the various 
recommendations and the reasons for providers to decline 
them.   
 
There were several important limitations to this project. The 
analysis was retrospective in nature, so there were no pre-
specified primary and secondary outcomes established for the 
pharmacy interventions. There was no control group to 
compare with those patients who received MTM services, and 
as such there is no way to attribute any improvement in patient 
health outcomes to the services rendered. Important measures 
such as quantifying the impact of the adherence interventions 
or obtaining regular laboratory values before and after the 
pharmacy interventions were not readily available, further 
weakening the overall impact that can be demonstrated. Since 
the project was conducted across several medical clinics, there 
was no systematic way to track why patients were or were not 
being referred and why only around 50% of those patients 
identified as eligible ultimately engaged with services. The 
limited funded time available for the pharmacist to dedicate to 
the project also limited the scope of what could have been 
accomplished. Not every medical clinic approached by the Tri-
County Health Department entered into a partnership with this 
organization to utilize the various services offered, so it is 
possible that those clinics who accepted the agreement had a 
greater need for resources or were more open to personnel 
assisting in the care of their patients. Also, not every provider 
in the partnering offices made referrals for MTM services. 
Finally, all of these clinics that partnered with the health 
department were geographically located in Denver or 
surrounding areas, so it is unknown whether this model would 
perform well in other areas, such as rural communities. Further 
data need to be collected to explore whether medical offices 
could benefit by hiring a clinical pharmacist as part of their 
overall care team, and whether the cost savings produced by 
that person would more than offset their salary requirements. 
The total time involved to deliver these services becomes an 
important consideration when considering the sustainability of 
the model. Patient satisfaction surveys were voluntary and only 
given at the completion of all TCHD services.  It would have 
been much more effective to deliver a satisfaction survey 
specific to the MTM services and deliver it directly after the 
patient completed their consultations. 
 
This manuscript presents a novel method for delivering MTM 
services to patients. It has been widely observed that the 
current delivery of MTM is suboptimal, and that improvements 
need to be made to the process.11,20 Key components identified 
to improve the process include better engagement with the 
patient’s pharmacist and provider, which this model 
accomplished. The manuscript also highlights the role of a local 
health department in providing valuable educational resources 
and integrating them as part of the patient’s usual care at the 
medical office. 
 
CONCLUSION 
Integrated MTM services provided on-site to local medical 
offices as part of a public health partnership had positive 
impacts on those clinics, and on the patients served. Placing a 
pharmacist into the clinic as part of the medical visit may 
overcome certain barriers seen with current MTM delivery. 
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Table 1: Specifics of patients receiving medication therapy management consultations (n=180) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Parameter n (%) Baseline 
value 
(mean) 
Exit value P value 
Diagnosis of hypertension 107 (59%) 
 
 
Hypertensive patients 
identified as non-
adherent to one or 
more medications 
92 (86%) 
Hypertensive patients 
demonstrating lower 
blood pressure readings 
from baseline after 
MTM services 
22 (21%) 139/82 133/79 p=0.013(systolic) 
 
p= 0.202 (diastolic) 
Hypertensive patients 
maintaining consistent 
blood pressure under 
140/90 for at least 9 
months 
24 (22%)  
Diagnosis of diabetes 127 (71%) 
 
Patients with diabetes 
identified as non-
adherent to one or 
more medications 
101 (80%) 
Patients with diabetes 
demonstrating lower 
A1C values from 
baseline after MTM 
services 
27 (21%) 7.65% 7.33% p=0.112 
Patients with diabetes 
maintaining consistent 
A1C values below 9% 
51 (40%)  
Reduction in weight from 
baseline 
71 (39%) 
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Table 2. Changes on patients’ health-related quality of life questions after receiving services 
 
Quality of life question Response 
rate 
n (%) 
improved 
from 
baseline 
Q1)Would you say that in general your health is: excellent/very good/good/fair/poor 82 
responded 
  31 (38%) 
Q1 responses before 
services n (%) 
Excellent: 
5 (6%) 
Very good: 
20 (24%) 
Good: 
40 (49%) 
Fair: 
15 (18%) 
Poor: 
2 (3%) 
 
Q1 responses after 
services n (%) 
Excellent: 
5 (6%) 
Very good: 
20 (24%) 
Good: 
40 (49%) 
Fair: 
15 (18%) 
Poor: 
2 (3%) 
 
Q2) Now thinking about your physical health, which includes physical illness and injury, for how 
many days during the past 30 days was your physical health not good? 
80 
responded 
29 (36%) 
Q3) Now thinking about your mental health, which includes stress, depression, and problems 
with emotions, for how many days during the past 30 days was your mental health not good? 
83 
responded 
24 (29%) 
Q4) During the past 30 days, for about how many days did poor physical or mental health keep 
you from doing your usual activities, such as self-care, work, or recreation? 
82 
responded 
16 (20%) 
Q5) Think about your current medical conditions. How confident are you that you can manage 
these medical conditions day-to-day: very confident/somewhat confident/not very confident 
62 
responded 
14 (17%) 
Q5 responses 
 n (%) 
Very confident: 
53 (65%) 
Somewhat 
confident:  
25 (30%) 
Not very 
confident:  
4 (5%) 
 
Q6) I have increased my knowledge on how to manage my health: Strongly agree, agree, 
neither agree or disagree, disagree, strongly disagree 
Q6 responses  
n (%) 
Strongly 
agree: 
43 (53%) 
Agree: 
32 (39%) 
Neither 
agree or 
disagree: 
6 (7%) 
Disagree: 
0 (0%) 
Strongly 
disagree: 
1 (1%) 
PHQ4 scale 
(anxiety/depression) 
73 patients responded at 
baseline and after 
receiving services 
17 patients demonstrated 
improvements in scale score (23%) 
 
 
Figure 1.  Provider Acceptance to Pharmacy MTM Recommendations 
 (number of recommendations, % of all recommendations) 
 
 
